BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/28/2026 8:52:22 AM | Browse: 2 | Download: 4
 |
Received |
|
2025-11-12 08:05 |
|
Peer-Review Started |
|
2025-11-12 08:05 |
|
First Decision by Editorial Office Director |
|
2025-12-23 09:59 |
|
Return for Revision |
|
2025-12-23 09:59 |
|
Revised |
|
2026-01-06 05:11 |
|
Publication Fee Transferred |
|
2026-01-19 06:12 |
|
Second Decision by Editor |
|
2026-02-28 02:28 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-28 02:43 |
|
Articles in Press |
|
2026-02-28 02:43 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-05-07 10:31 |
|
Publish the Manuscript Online |
|
2026-05-28 08:52 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Observational Study |
| Article Title |
Thyroid-stimulating hormone levels and suicide attempts in Chinese patients with first-episode drug-naïve major depressive disorder
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Han-Xu Deng, Yao-Zhi Liu, Lin Yang, Jun-Jun Liu, Feng-Nan Jia, Xue-Li Zhao, Xing-Zhi Xia, Xiang-Yang Zhang and Xiang-Dong Du |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Medical research key project of Jiangsu Provincial Health Commission |
No. K2023015 |
| Suzhou Major Diseases Clinical Multi-Center Research Project |
No. DZXYJ202414 |
| Scientific and Technological Key Program of Suzhou |
No. SYW2024008 |
| Key Discipline of Psychiatry in Suzhou |
No. SZXK202521 |
|
| Corresponding Author |
Xiang-Dong Du, Chief Physician, Professor, Department of Psychiatry, Suzhou Guangji Hospital, The Affiliated Guangji Hospital of Soochow University, No. 11 Guangqian Road, Suzhou 215004, Jiangsu Province, China. xiangdong-du@163.com |
| Key Words |
Thyroid-stimulating hormone; Suicide attempts; Thyroid dysfunction; First-episode drug naïve; Major depressive disorder; Non-linear relationship |
| Core Tip |
This study investigates the relationship between thyroid-stimulating hormone (TSH) levels and suicide attempts in first-episode drug-naïve major depressive disorder patients. The results show a positive independent correlation between TSH levels and suicide attempts, with a significant increase in the correlation when TSH exceeds 5.43 µIU/mL. This finding provides a new biomarker-based perspective for early suicide risk identification in depressed patients. |
| Publish Date |
2026-05-28 08:52 |
| Citation |
Deng HX, Liu YZ, Yang L, Liu JJ, Jia FN, Zhao XL, Xia XZ, Zhang XY, Du XD. Thyroid-stimulating hormone levels and suicide attempts in Chinese patients with first-episode drug-naïve major depressive disorder. World J Psychiatry 2026; 16(6): 116435 |
| URL |
https://www.wjgnet.com/2220-3206/full/v16/i6/116435.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v16.i6.116435 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
